Related Experiment Videos
Monoamine oxidase activity in the fetal lung and liver
Abstract:
Monoamine oxidase (MAO) in lung and liver is important in the degradation of circulating 5-hydroxytryptamine. These sites of MAO activity have been investigated histochemically in the human fetus of 12 to 18 weeks gestation. Enzyme activity could be demonstrated in the liver by both tryptamine and adrenaline oxidation. In the lung, MAO activity was present only when adrenaline was used to substrate. It may be, therefore, that in the premature baby the capacity of MAO to metabolize 5-hydroxytryptamine is not fully developed, which could lead to deleterious effects on pulmonary function.
Insights
Monoamine oxidase (MAO) activity in fetal lungs is limited, potentially impairing 5-hydroxytryptamine metabolism. This suggests underdeveloped MAO capacity in premature infants may negatively impact pulmonary function.
Area of Science:
- Biochemistry
- Developmental Biology
- Histochemistry
Background:
- Monoamine oxidase (MAO) plays a crucial role in metabolizing circulating 5-hydroxytryptamine (serotonin).
- Understanding MAO activity in fetal development is essential for assessing neonatal health, particularly pulmonary function.
Purpose of the Study:
- To investigate the histochemical localization and activity of monoamine oxidase (MAO) in the human fetal liver and lung.
- To assess the developmental stage of MAO's capacity to metabolize 5-hydroxytryptamine in fetuses between 12 and 18 weeks of gestation.
Main Methods:
- Histochemical analysis of MAO activity using tryptamine and adrenaline as substrates.
- Examination of fetal liver and lung tissues from human fetuses aged 12 to 18 weeks gestation.
Main Results:
- MAO activity was detected in the fetal liver using both tryptamine and adrenaline.
- In the fetal lung, MAO activity was only observed when adrenaline was used as the substrate, not tryptamine.
- This indicates a substrate-specific difference in MAO activity between fetal liver and lung.
Conclusions:
- The fetal lung's MAO activity appears less developed than the liver's, particularly for 5-hydroxytryptamine metabolism.
- In premature infants, potentially underdeveloped MAO capacity to metabolize 5-hydroxytryptamine could adversely affect pulmonary function.
- Further research is warranted to confirm these findings and explore clinical implications for neonatal respiratory health.